NZ192422A - Benzoxadiazoles and benzothiadiazoles with 1,4-dihydropyridine moiety pharmaceutical compositions - Google Patents

Benzoxadiazoles and benzothiadiazoles with 1,4-dihydropyridine moiety pharmaceutical compositions

Info

Publication number
NZ192422A
NZ192422A NZ192422A NZ19242279A NZ192422A NZ 192422 A NZ192422 A NZ 192422A NZ 192422 A NZ192422 A NZ 192422A NZ 19242279 A NZ19242279 A NZ 19242279A NZ 192422 A NZ192422 A NZ 192422A
Authority
NZ
New Zealand
Prior art keywords
benzoxadiazoles
benzothiadiazoles
pharmaceutical compositions
dihydropyridine moiety
dihydropyridine
Prior art date
Application number
NZ192422A
Other languages
English (en)
Inventor
P Neumann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Priority to NZ199437A priority Critical patent/NZ199437A/en
Publication of NZ192422A publication Critical patent/NZ192422A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NZ192422A 1978-12-18 1979-12-17 Benzoxadiazoles and benzothiadiazoles with 1,4-dihydropyridine moiety pharmaceutical compositions NZ192422A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ199437A NZ199437A (en) 1978-12-18 1982-01-07 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydro-3-methoxycarbonylpyridine-5-carboxylic acid isopropyl ester and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1283578A CH639659A5 (de) 1978-12-18 1978-12-18 Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.

Publications (1)

Publication Number Publication Date
NZ192422A true NZ192422A (en) 1982-09-14

Family

ID=4386824

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ192422A NZ192422A (en) 1978-12-18 1979-12-17 Benzoxadiazoles and benzothiadiazoles with 1,4-dihydropyridine moiety pharmaceutical compositions

Country Status (18)

Country Link
JP (1) JPS5583783A (zh)
AU (1) AU536055B2 (zh)
BE (1) BE880591A (zh)
CH (1) CH639659A5 (zh)
CY (1) CY1321A (zh)
DE (1) DE2949491A1 (zh)
FR (1) FR2444681A1 (zh)
GB (2) GB2103203B (zh)
HK (1) HK16086A (zh)
IE (1) IE49496B1 (zh)
IT (1) IT1164097B (zh)
KE (1) KE3593A (zh)
MY (1) MY8500130A (zh)
NL (2) NL193066C (zh)
NZ (1) NZ192422A (zh)
SE (1) SE445219B (zh)
SG (1) SG97585G (zh)
ZA (1) ZA796842B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
CH655658B (zh) * 1980-09-18 1986-05-15
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
IL68975A (en) * 1982-06-15 1987-01-30 Sandoz Ag 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylic acid ester derivatives in optically active form,their preparation and pharmaceutical compositions containing them
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
GB8626217D0 (en) * 1986-11-03 1986-12-03 Sandoz Ltd Pharmaceutical compositions
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
CN1649614A (zh) 2002-02-22 2005-08-03 新河药品股份有限公司 活性剂传递系统和保护及施用活性剂的方法
WO2005023787A1 (en) * 2003-09-10 2005-03-17 Shasun Chemicals And Drugs Limited Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
CN103613584B (zh) * 2013-11-27 2016-04-27 沈阳药科大学 一种伊拉地平合成产物后处理的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2616991A1 (de) * 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5373327A (en) * 1976-12-13 1978-06-29 Matsushita Electric Ind Co Ltd Power source system
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat

Also Published As

Publication number Publication date
AU536055B2 (en) 1984-04-19
IE792445L (en) 1980-06-18
FR2444681B1 (zh) 1982-10-29
HK16086A (en) 1986-03-14
SG97585G (en) 1986-07-18
IT1164097B (it) 1987-04-08
DE2949491C2 (zh) 1988-10-27
NL193066B (nl) 1998-05-06
JPH0369910B2 (zh) 1991-11-05
SE7910188L (sv) 1980-06-19
KE3593A (en) 1986-02-07
FR2444681A1 (fr) 1980-07-18
GB2037766A (en) 1980-07-16
GB2037766B (en) 1983-02-16
GB2103203A (en) 1983-02-16
BE880591A (fr) 1980-06-13
CY1321A (en) 1986-06-27
NL7909024A (nl) 1980-06-20
SE445219B (sv) 1986-06-09
GB2103203B (en) 1983-06-08
ZA796842B (en) 1981-07-29
MY8500130A (en) 1985-12-31
IT7951095A0 (it) 1979-12-14
AU5389679A (en) 1980-06-26
NL193066C (nl) 1998-09-08
CH639659A5 (de) 1983-11-30
NL990014I1 (nl) 1999-07-01
JPS5583783A (en) 1980-06-24
IE49496B1 (en) 1985-10-16
DE2949491A1 (de) 1980-06-26

Similar Documents

Publication Publication Date Title
NZ192422A (en) Benzoxadiazoles and benzothiadiazoles with 1,4-dihydropyridine moiety pharmaceutical compositions
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
IL58123A0 (en) 4,5-diaryl-2-nitroimidazoles their preparation and pharmaceutical compositions containing them
ZA791732B (en) Carbazolyl-(4)-oxypropanolamine derivatives,preparation thereof and pharmaceutical compositions containing these compounds
PH14086A (en) Cyclosporin derivatives and pharmaceutical compositions thereof
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
PH16519A (en) 1,2,3,4-tetrahydro-2-amino-5-oxy-naphthalene derivatives and their pharmaceutical compositions
NZ187617A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
NZ192421A (en) Benzoxadiazoles and benzothiadiazoles with 1,4-dihydroxy-pyridine moiety and pharmaceutical compositions
PH15791A (en) Pharmaceutical composition containing 3,4-dihydro-3-oxoquinoxalines
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
EP0018417A4 (en) New piperidine derivatives and pharmaceutical compositions containing them.
NZ191185A (en) 1,2,3-triazolecarboxylic acid amides and biocidal compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ190092A (en) 1-benzyl-1,2,3,6-tetrahydropyridine derivatives and pharmaceutical compositions
NZ187825A (en) 1,2,4-oxadiazole derivatives and pharmaceutical compositions
NZ189769A (en) Benzylidene derivatives and pharmaceutical compositions
IL57720A0 (en) Phenylpiperidine derivatives,their preparation and pharmaceutical compositions containing them
NZ190278A (en) 6,7-benzomorphan derivatives and pharmaceutical compositions
NZ189703A (en) N'-glucofuranosid-6-yl-n3-nitroso-ureas and pharmaceutical compositions
NZ191959A (en) 1,2,4-triazol derivatives and pharmaceutical compositions
IL56457A (en) 1,10'a beta-dimethyl-9,10-dihydroergocristine,its preparation and pharmaceutical compositions containing it
NZ190665A (en) S-benzylcysteine derivatives and pharmaceutical compositions